IGM Biosciences, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
IGM Biosciences, Inc. reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $2.07 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2025-03-06
- IGM Biosciences, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $2.07M, a 43.43% decline from fiscal 2023.
- IGM Biosciences, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $3.65M, a 26.45% increase from fiscal 2022.
- IGM Biosciences, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $2.89M, a 66.65% increase from fiscal 2021.
- IGM Biosciences, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2021 was $1.73M, a 56.97% increase from fiscal 2020.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2024-12-31 | $2.07M 10-K · filed 2025-03-06 |
| 2023-12-31 | $3.65M 10-K · filed 2025-03-06 |
| 2022-12-31 | $2.89M 10-K · filed 2025-03-06 |
| 2021-12-31 | $1.73M 10-K · filed 2024-03-07 |
| 2020-12-31 | $1.10M 10-K · filed 2023-03-30 |
| 2019-12-31 | $707.00K 10-K · filed 2022-03-29 |
| 2018-12-31 | $448.00K 10-K · filed 2021-03-30 |